Peter MacCallum Cancer Centre:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Peter MacCallum Cancer Centre - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9313
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Peter MacCallum Cancer Centre (Peter Mac) is a provider of public health services. It serves as a cancer research, treatment and education centre. The centre provides wide range of services including diagnostic, radiation therapy, treatment, cancer information and support services. It works in collaboration with various organizations and networks domestically and across the globe to provide cancer services. Peter Mac is headquartered in Melbourne, Victoria, Australia.

Peter MacCallum Cancer Centre – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Peter MacCallum Cancer Centre, Medical Devices Deals, 2012 to YTD 2018 9
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 11
Telix Pharma Enters into Research Partnership with University of Melbourne and Peter MacCallum Cancer Centre 12
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 13
Peter MacCallum Cancer Centre – Key Employees 14
Peter MacCallum Cancer Centre – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Recent Developments 16
Government and Public Interest 16
Aug 13, 2018: New insight into genetic drivers of aggressive prostate cancer 16
Jun 26, 2018: New understanding of how the immune system responds to breast cancer 17
Mar 01, 2018: Research into rare cancers receives funding boost 18
Feb 06, 2018: Commonwealth of Australia: Ground-breaking ovarian cancer project to save lives 19
Dec 13, 2017: Study Reveals A Role For Micro-RNAS In Cancer Cell Survival 21
Oct 17, 2017: New Potential Treatment for Prostate Cancer Receives Boost 22
Oct 09, 2017: Starpharma and Peter Mac Cancer Centre awarded DEP Grant 23
Aug 17, 2017: New Way To Empower The Immune System To Detect And Kill Cancer 24
May 03, 2017: New Pathway For Blood Cancer Therapies 25
Mar 01, 2017: Combination of ground-breaking treatments offer powerful new path for blood cancer therapies 26
Other Significant Developments 27
Feb 27, 2017: Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia University Medical Center and Peter MacCallum Cancer Centre 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Key Facts 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peter MacCallum Cancer Centre, Deals By Therapy Area, 2012 to YTD 2018 8
Peter MacCallum Cancer Centre, Medical Devices Deals, 2012 to YTD 2018 9
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 11
Telix Pharma Enters into Research Partnership with University of Melbourne and Peter MacCallum Cancer Centre 12
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 13
Peter MacCallum Cancer Centre, Key Employees 14
Peter MacCallum Cancer Centre, Joint Venture 15

List of Figures
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peter MacCallum Cancer Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Peter MacCallum Cancer Centre, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Peter MacCallum Cancer Centre:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United Rentals Inc:戦略・SWOT・企業財務分析
    United Rentals Inc - Strategy, SWOT and Corporate Finance Report Summary United Rentals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tel-Instrument Electronics Corp.:企業の戦略・SWOT・財務分析
    Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report Summary Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Silver Bull Resources, Inc.:企業の戦略・SWOT・財務分析
    Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Warpaint London plc (W7L):企業の財務・戦略的SWOT分析
    Warpaint London plc (W7L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kiromic Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kiromic Inc (Kiromic) is a biotechnology company focused on developing immuno-oncology therapies. Its pipeline products include BSK01, an injectable drug that harness dendritic cells for the treatment of solid and hematological malignancies; BSK02, a synthetic oral cancer immunotherapy compo …
  • Resolute Energy Corp (REN):石油・ガス:M&Aディール及び事業提携情報
    Summary Resolute Energy Corp (Resolute), a subsidiary of Resolute Holdings LLC, is an oil and gas company that acquires and operates large-scale oil and gas properties. The company mangaes complex enterprise and undertakes complex transactions. It offers considerable acquisitions of producing proper …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • First Republic Bank:戦略・SWOT・企業財務分析
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Shangri-La Hotels (Malaysia) Berhad:企業の戦略・SWOT・財務情報
    Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Mitsubishi Estate Co., Ltd. (8802):企業の財務・戦略的SWOT分析
    Mitsubishi Estate Co., Ltd. (8802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • The Broad Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Gildan Activewear Inc.:戦略・SWOT・企業財務分析
    Gildan Activewear Inc. - Strategy, SWOT and Corporate Finance Report Summary Gildan Activewear Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Crown Bioscience Inc (6554):医療機器:M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • Gordon Food Service Inc:企業の戦略的SWOT分析
    Gordon Food Service Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Braeburn Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Braeburn Inc (Braeburn), formerly Braeburn Pharmaceuticals Inc (Braeburn), is a biopharmaceutical company that develops medicines for the treatment of opioid addiction. The company’s lead product candidate CAM2038 is a weekly and monthly subcutaneous injection depot formulation of buprenorph …
  • Attunity Ltd (ATTU):企業の財務・戦略的SWOT分析
    Summary Attunity Ltd (Attunity) is a technology company that provides data management software, cloud database replication solutions, and google cloud database tools. The company provides data management software solutions that enable access, sharing, management, and distribution of data. It offers …
  • Medigard Ltd (MGZ):医療機器:M&Aディール及び事業提携情報
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd, is a medical device company that designs and develops retractable safety medical devices. The company provides products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and …
  • Vanderbilt University:製薬・医療:M&Aディール及び事業提携情報
    Summary Vanderbilt University (Vanderbilt) is a medical and research university that provides professional degrees. The university offers graduate and undergraduate degrees in the fields of engineering, music, liberal arts and sciences, education and human development. It provides services such as c …
  • Analog Devices, Inc.:企業の戦略・SWOT・財務情報
    Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report Summary Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NanoPass Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and commercializes intradermal delivery solutions for vaccines and drugs. The company's product include MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its micronjet microneed …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆